Pre-Conference Workshops

Tuesday, October 2, 2018


BASIC SCIENCE WORKSHOP 1: CAN THE BLOCKS TO EFFECTIVE THERAPY

FOR HPV INFECTION BE OVERCOME?

09:00 - 10:30 C4.9

 

Chair: Tomas Broker (USA)

 

 

Chair: Kelvin Tuong (Australia)

 

09:00

IMMUNOLOGY OF THE SKIN 
Invited Speaker: Kelvin Tuong (Australia)

 

09:30

MANIPULATING THE PD-1 PATHWAY TO IMPROVE IMMUNITY.
Invited Speaker: TBA TBA ()

 

10:00

FIGHTING VIRAL INFECTIONS AND VIRUS-DRIVEN TUMORS WITH CYTOTOXIC CD4+ T CELLS. 
Invited Speaker: Riccardo Dolcetti (Australia)

 

CLINICAL WORKSHOP 1: DEVELOPING CLINICAL CAPACITY IN LMIC

09:00 - 10:30 C4.4
 Chair: Alec Ekoroma (New Zealand) 
 Chair: Deborah Bateson (Australia) 
09:00PRACTICALITIES OF CERVICAL SCREENING IN INDIA/SRI LANKA & BHUTAN
Invited Speaker: Neerja Bhatla (India)
 
09:15CLINICAL CHALLENGES FACING SERVICE DELIVERY IN ASIA PACIFIC
Invited Speaker: Kirsten Black (Australia)
 
09:30RAPID HPV TESTING IN THE FIELD. VIA (PNG)
Invited Speaker: Andrew Vallely (Australia)
 
10:00VACCINATION & SCREENING IN LMIC
Invited Speaker: Heather Cubie (United Kingdom)
 
10:15PANEL DISCUSSION: IS THE END NIGH FOR VIA?
 


PUBLIC HEALTH WORKSHOP 1: MOVING FORWARD WITH HPV 

VACCINATION IN HIC

11:00 - 12:30 C4.5
 Chair: Anna R Giuliano (USA)
 
 Chair: Julia Brotherton (Australia) 
09:00
SCENE SETTING ON GLOBAL PROGRESS IN HPV VACCINATION
Invited Speaker: Anna R Giuliano (USA)
 
09:05
IMPLEMENTATION OF TWO DOSE, NONAVALENT, GENDER NEUTRAL VACCINATION IN NEW ZEALAND
Invited Speaker: Nikki Turner (New Zealand)
 
09:20NONAVALENT HPV VACCINE SAFETY: THE US EXPERIENCE
Invited Speaker: Julianne Gee (USA)
 
09:35
TARGETED MSM HPV VACCINATION PROGRAM IN THE UK: WHY, HOW AND LESSONS LEARNED
Invited Speaker: Mark Jit (United Kingdom)
 
09:50HIDDEN INEQUALITIES IN HPV VACCINE UPTAKE. WHO IS MISSING OUT ON HPV VACCINE IN HIC, WHY, AND WHAT CAN WE DO ABOUT IT?
Invited Speaker: Gregory Zimet (USA)
 
10:05
REACHING AND INFORMING: EFFECTIVE ENGAGEMENT METHODS TO SUPPORT HPV VACCINE UPTAKE
Invited Speaker: Jasmin Tiro (USA)
 
10:20DISCUSSION

BASIC SCIENCE WORKSHOP 2: WHAT ARE THE GENETIC/STOCHASTIC DETERMINANTS OF PERSISTING INFECTION WITH HIGH RISK HPVS?

11:00 - 12:30 C4.9
 Chair: Karl Munger (USA) 
 Chair: Matt Brown (Australia) 
11:00SOMATIC HOST CELL ALTERATIONS IN HPV CARCINOGENESIS.
Invited Speaker: Nicolas Wentzensen (USA)
 
11:30PATTERNS OF PERSISTENT HPV INFECTION AFTER TREATMENT FOR CERVICAL INTRAEPITHELIAL NEOPLASIA
Invited Speaker: Matt Brown (Australia)
 
12:00DETERMINANTS OF VIRAL PERSISTENCE 
Invited Speaker: Karl Munger ()
 

 

CLINICAL WORKSHOP 2: HPV RELATED DISEASES OF THE CERVIX & BEYOND

11:00 - 12:30 C4.4
 Chair: Anne Olssen (Australia) 
 Chair: Annabelle Farnsworth (Australia) 
11:00DIAGNOSIS AND MANAGEMENT OF HPV-RELATED VIN3, VAIN3
Invited Speaker: Elmar Joura (Austria)
 
11:20DIFFERENTIAL DIAGNOSIS OF NON-HPV RELATED VULVAL DISEASE
Invited Speaker: Gayle Fischer (Australia)
 
11:40NEW DIRECTIONS IN THE DIAGNOSIS AND MANAGEMENT OF ICC
Invited Speaker: Lynette Denny (South Africa)
 
12:00NEW DIRECTIONS IN COLPOSCOPY
Invited Speaker: Alison Brand (Australia)
 
12:20PANEL DISCUSSION
 


PUBLIC HEALTH WORKSHOP 2: STORIES OF SUCCESS: HPV VACCINATION PROGRAMS IN LOW AND MIDDLE INCOME COUNTRIES

09:00 - 10:30 C4.5
 Chair: D.Scott LaMontagne (USA) 
 Chair: Phionah Atuhebwe (Uganda)
 
11:00INTRODUCTION
Invited Speaker: D.Scott LaMontagne (USA)
 
11:02OVERVIEW OF HPV INTRODUCTION IN LMIC
Invited Speaker: Anagha Loharikar (USA)
 
11:12Missing middle – country that has to co-financing
Invited Speaker: Ertenisa Hamilton (Guyana)
 
11:22Crisis communication. Overcoming anti-vaccination sentiments and fear of vaccinations/injections in preparing and launching a program.
Invited Speaker: Rodica Scutelnic (Moldova)
 
11:32How to do multi age catch up
Invited Speaker: Portia Manangazira (Zimbabwe)
 
11:42Incorporating HPV vaccination into school health programs
Invited Speaker: Deepa Gamage (Sri Lanka)
 
11:52Access - challenges and facilitators
Invited Speaker: Maria Wilda Silva (Philippines)
 
12:02Summary of key learnings from countries
Invited Speaker: D.Scott LaMontagne (USA)
 
12:05PANEL DISCUSSION

BASIC SCIENCE WORKSHOP 3: IMMUNOLOGY OF HPV INFECTIONS

13:30 - 15:00 C4.9
 Chair: Peter Stern (United Kingdom) 
 Chair: TBA () 
13:30ADVANCES IN IMMUNOTHERAPHY: ROLE OF CAR-T CELLS
Invited Speaker: Peter Stern (United Kingdom)
 
14:00VIRAL REGULATION OF CELL FUNCTION AND IMMUNITY IN THE SKIN 
Invited Speaker: Merilyn Hibma (New Zealand)
 
14:15HUMAN PAPILLOMAVIRUS-DRIVEN IMMUNE DEVIATION: CHALLENGE AND NOVEL OPPORTUNITY FOR IMMUNOTHERAPY.
Invited Speaker: Sigrun Smola (Germany)
 
14:30THERAPEUTIC VACCINES AGAINST HPV-ASSOCIATED CANCER
Invited Speaker: Marij Welters (The Netherlands)
 

CLINCAL WORKSHOP 3: HPV AND ANAL CANCER IN MSM

13:30 - 15:00 C4.4
 Chair: Dave Templeton (Australia) 
 Chair: J. Michael Berry-Lawhorn (USA) 
13:30PRIORITISATION ALGORITHMS FOR TARGETED TREATMENT
Invited Speaker: Isobel Mary Poynten (Australia)
 
13:45IMPROVING THE CLINICAL DIAGNOSIS OF ANAL HSIL
Invited Speaker: Naomi Jay (USA)
 
14:00ANAL HSIL - TO TREAT OR NOT TO TREAT?
Invited Speaker: Joel Palefsky (USA)
 
14:15LATEST TREATMENTS FOR ANAL CANCER
Invited Speaker: Susan Carroll (Australia)
 
14:30PANEL DISCUSSION: WHAT IS THE CURRENT STATE OF PLAY FOR SCREENING?
 

PUBLIC HEALTH WORKSHOP 3: WE CAN PREVENT CERVICAL CANCER: AN AUSTRALIAN PERSPECTIVE ON CLOSING THE GAP IN ABORIGINAL AND 

TORRES STRAIT ISLANDER HEALTH

13:30 - 15:00 C4.5
 Chair: Julia Brotherton (Australia) 
 Chair: Lisa Whop (Australia) 
13:30INTRODUCTION
Invited Speaker: Lisa Whop (Australia)
 
13:40THE NATIONAL INDIGENOUS CERVICAL SCREENING PROJECT: PRINCIPLES OF CONSULTATION AND COLLABORATION, CAPACITY BUILDING, AND RECIPROCITY IN ACTION
Invited Speaker: Abbey Diaz (Australia)
 
13:55FINDINGS FROM SCREENING MATTERS: IS THE RENEWED CERVICAL SCREENING PROGRAM ON TRACK TO DELIVER BETTER HEALTH TO ABORIGINAL AND TORRES STRAIT ISLANDER WOMEN? 
Invited Speaker: Tamara Butler (Australia)
 
14:10COULD SELF-COLLECTION BE AN EQUITABLE OPTION FOR ABORIGINAL WOMEN? MODELLING ITS IMPACT COMPARED TO CLINICIAN COLLECTED TESTING IN THE AUSTRALIAN SETTING 
Invited Speaker: Megan Smith (Australia)
 
14:25HPV VACCINATION FOR ABORIGINAL ADOLESCENTS AND THEIR COMMUNITIES: WHAT DO WE KNOW ABOUT COVERAGE AND ACCEPTABILITY?
Invited Speaker: Rebecca Guy (Australia)
 
14:40DISCUSSION AND INVITED RESPONSES FROM INTERNATION INDIGENOUS DELEGATES

Wednesday, October 3, 2018

BASIC SCIENCE WORKSHOP 4: NATURAL HISTORY OF HPV

09:00 - 10:30 C4.9
 Chair: Laimonis Laimins (USA) 
 Chair: Frank Stubenrauch (Germany) 
09:00HUMAN PAPILLOMAVIRUS AND THE DNA DAMAGE RESPONSE
Invited Speaker: Laimonis Laimins (USA)
 
09:25HPV: EPITHELIAL TROPISMS AND THE DEVELOPMENT OF NEOPLASIA
Invited Speaker: John Doorbar (United Kingdom)
 
09:45HPV AND HEAD AND NECK CANCER 
Invited Speaker: Nigel McMillan (Australia)
 
10:00HUMAN PAPILLOMAVIRUS AND THE STROMA: BIDIRECTIONAL CROSSTALK DURING THE VIRUS LIFE CYCLE AND CARCINOGENESIS.
Invited Speaker: Paul Lambert (USA)
 

CLINICAL WORKSHOP 4: CLINICAL PERSPECTIVES IN SPECIFIC POPULATIONS

09:00 - 10:30 C4.4
 Chair: Richard Turner (Australia) 
 Chair: Marlene Kong (Australia) 
09:00HPV SCREENING AND DISEASE IN IMMUNE-COMPROMISED WOMEN
Invited Speaker: Anna-Barbara Moscicki (USA)
 
09:15ABORIGINAL AND TORRES STRAIT ISLANDERS – ACCESS, ACCEPTABILITY, DISEASE PRESENTATIONS
Invited Speaker: Marlene Kong (Australia)
 
09:30INCLUSIVE SERVICES FOR THE TRANSGENDERED
Invited Speaker: Tba Tba ()
 
09:45CHILD SURVIVORS OF SEXUAL ABUSE (VACCINATION and SCREENING)
Invited Speaker: Yasmin Jayasinga (Australia)
 
10:00PANEL DISCUSSION
 

PUBLIC HEALTH WORKSHOP 4: HPV TESTING IN LOW AND MIDDLE INCOME COUNTRIES: PROVIDING HOPE TO THE PRE-HPV VACCINATION COHORTS

09:00 - 10:30 C4.5
 Chair: Philip Castle (USA) 
 Chair: John Kaldor (Australia) 
09:00INTRODUCTION
Invited Speaker: Philip Castle (USA)
 
09:01POINT OF CARE HPV TESTING AS A SCREEN AND TREAT PROGRAM: THE PAPUA NEW GUINEA EXPERIENCE
Invited Speaker: Pamela Tolliman (Australia)
 
09:16REAL WORLD EXPERIENCE WITH HPV BASED SCREENING IN EL SALVADOR
Invited Speaker: Mauricio Maza (El Salvador)
 
09:31INCORPORATING HPV TESTING INTO CERVICAL SCREENING IN BOTSWANA
Invited Speaker: Doreen Ramolgola-Masire (Botswana)
 
09:46SELF-SAMPLING WITH POINT OF CARE HPV TESTING IN MALAYSIA: PROJECT ROSE
Invited Speaker: Yin Ling Woo (Malaysia)
 
10:01FACILITATED DISCUSSION OF ISSUES RAISED AND WAY FORWARD
Invited Speaker: Philip Castle (USA)
Invited Speaker: John Kaldor (Australia)
 

BASIC SCIENCE WORKSHOP 5: VIRAL ENTRY

11:00 - 12:00 C4.9
 Chair: Martin Sapp (USA) 
 Chair: Tony Cunningham (Australia) 
11:00INFECTION AND TRANSPORT OF HERPES SIMPLEX VIRUS TYPE 1 IN NEURONS: ROLE OF THE CYTOSKELETON.
Invited Speaker: Tony Cunningham (Australia)
 
11:15HUMAN PAPILLOMAVIRUS TYPE 16 ENTRY AND INTRACELLULAR TRAFFICKING IN HUMAN KERATINOCYTES
Invited Speaker: (USA)
 
11:30TETRASPANIN ASSEMBLIES IN VIRUS INFECTION
Invited Speaker: Luise Florin (Germany)
 
11:45A NEW CELL CULTURE MODEL TO GENETICALLY DISSECT THE COMPLETE HUMAN PAPILLOMAVIRUS LIFE CYCLE
Invited Speaker: Martin Sapp (USA)
 
 

CLINCIAL WORKSHOP 5: CLINICAL UPDATE OF HPV IN THE HEAD AND NECK

11:00 - 12:00 C4.4
 Chair: Craig Derkay (USA) 
11:00SHOULD WE BE SCREENING FOR ORAL HPV-RELATED DISEASE?
Invited Speaker: Paolo Campisi (Canada)
 
11:15EARLY EFFECTS OF HPV VACCINATION ON RRP INCIDENCE IN AUSTRALIA
Invited Speaker: Alan Cheng (Australia)
 
11:15ANTI-PD1 THERAPY FOR HPV-ASSOCIATED RRP
Invited Speaker: Lori Wirth (USA)
 
11:15IMMUNOTHERAPY - THE 4TH ARMAMENTARIUM FOR HPV-ASSOCIATED HEAD AND NECK CANCERS
Invited Speaker: Sara Pai (USA)
 
11:30MINIMALLY INVASIVE (ROBOTIC) SURGERY FOR HPV-RELATED OROPHARYNGEAL CANCER
Invited Speaker: Jonathan Clark (Australia)
 
11:45NEW STAGING SYSTEM FOR OROPHARYNGEAL HEAD AND NECK CANCER
Invited Speaker: Bruce Haughey (USA)
 

 

PUBLIC HEALTH WORKSHOP 5: CERVICAL SCREENING IN HIGH INCOME COUNTRIES

11:00 - 12:00 C4.5
 Chair: Marion Saville (Australia) 
 Chair: Karen Canfell (Australia) 
11:00EVOLUTION OF CERVICAL SCREENING RECOMMENDATIONS IN THE USA AND ROLE OF MODELLING
Invited Speaker: Jane Kim (USA)
 
11:10THE EVIDENCE ON HPV NEGATIVE CANCERS: ANY IMPACT ON THE DECISION TO CO-TEST?
Invited Speaker: Philip Castle (USA)
 
11:20PRIMARY HPV SCREENING: EXTENDING THE INTERVAL BEYOND FIVE YEARS?
Invited Speaker: Hans Berkhof (The Netherlands)
 
11:30HPV FOCAL
Invited Speaker: Gina Ogilive (Canada)
 
11:40PERFORMANCE OF THE NEW HPV SCREENING PROGRAM IN AUSTRALIA - THE FIRST YEAR
Invited Speaker: Marion Saville (Australia)
 
11:50PRIMARY HPV TESTING IN NORTHERN EUROPE
Invited Speaker: Joaquim Dillner (Sweden)
 
 

BASIC SCIENCE WORKSHOP 6: HOW SIGNIFICANT ARE B-HPV INFECTIONS IN THE AETIOLOGY OF SQUAMOUS SKIN CANCER?

14:30 - 15:30 C4.9
 Chair: Massimo Tomassino (France) 
 Chair: Margaret Stanley (United Kingdom) 
14:30HUMAN PAPILLOMAVIRUSES AND SKIN CARCINOGENESIS: WHICH MODELS EXIST.
Invited Speaker: Massimo Tomassino (France)
 
14:50HUMAN BETA-PAPILLOMAVIRUS INFECTION AND KERATINOCYTE CARCINOMAS
Invited Speaker: Baki Akgül (Germany)
 
15:10GENETIC DISORDER AND SKIN CANCER: DO PAPILLOMAVIRUSES PLAY A ROLE?
Invited Speaker: TBA TBA ()
 
 

CLINCIAL WORKSHOP 6: HPV VACCINATION IN CLINICAL PRACTICE

14:30 - 15:30 C4.4
 Chair: Linda Ekert (USA) 
 Chair: Silvia De Sanjose (USA) 
14:30EVIDENCE OF EFFICACY FOR OLDER WOMEN
Invited Speaker: Rachel Skinner (Australia)
 
14:45HPV FASTER
Invited Speaker: Xavier Bosch (Spain)
 
15:00FAQS IN CLINICAL PRACTICE
Invited Speaker: Suzanne Garland (Australia)
 
15:00FAQS IN CLINICAL PRACTICE
Invited Speaker: Deborah Bateson (Australia)
 
15:15COMMUNICATING HPV MESSAGES
Invited Speaker: Julie Leask (Australia)
 
 PANEL DISCUSSION
 
 

PUBLIC HEALTH WORKSHOP 6: LIFTING OUR GAME: COMMUNICATION AND ENGAGEMENT STRATEGIES ABOUT HPV VACCINATION TO OVERCOME THE ORGANISED ANTI-VACCINATION MOVEMENT

14:30 - 15:30 C4.5
 Chair: Julia Brotherton (Australia) 
 Chair: Kevin Kelleher (Ireland) 
14:30EFFECTIVE TACTICS FOR CREATING A VACCINE SUPPORTIVE MEDIA ENVIRONMENT: A HISTORY OF THE STOP THE AVN MOVEMENT
Invited Speaker: Dave Hawkes (Australia)
 
14:30EFFECTIVE TACTICS FOR CREATING A VACCINE SUPPORTIVE MEDIA ENVIRONMENT: A HISTORY OF THE STOP THE AVN MOVEMENT
Invited Speaker: Tracey McDermott (Australia)
 
14:45HPV VACCINATION IN IRELAND: WINNING BACK PUBLIC TRUST
Invited Speaker: Kevin Kelleher (Ireland)
 
15:00RESPONDING TO HPV VACCINE CONCERNS IN DENMARK
Invited Speaker: Suzanne Kruger Kjaer (Denmark)
 
15:15HPV VACCINATION IN JAPAN: AN UPDATE ON A SEEMINGLY INTRACTABLE ISSUE
Invited Speaker: Sharon Hanley (Japan)
 
 

Keep Me Updated